Personalized mRNA Tumor Vaccine

BIOLOGICAL2 trials

Sponsors

Changhai Hospital, Stemirna Therapeutics

Conditions

Advanced Esophageal Squamous CarcinomaColorectal AdenocarcinomaEsophageal CancerGastric AdenocarcinomaNon Small Cell Lung CancerPancreatic Adenocarcinoma

Unknown Phase

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms

Changhai HospitalAdvanced Esophageal Squamous Carcinoma, Colorectal Adenocarcinoma, Gastric Adenocarcinoma +1

Start: 2018-05-01End: 2021-12-31Target: 24Updated: 2019-02-26

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer

Stemirna TherapeuticsEsophageal Cancer, Non Small Cell Lung Cancer

Start: 2019-10-18End: 2025-12-31Target: 24Updated: 2023-04-13

Related Papers

Personalized mRNA vaccine combined with PD-1 inhibitor therapy in a patient with advanced esophageal squamous cell carcinoma.

2024-08-254 citations

Phase I trial of personalized mRNA vaccine encoding neoantigen in patients with advanced digestive system neoplasms.

Journal of Clinical Oncology2020-05-2017 citations